Richards D M, Irving M H
Hope Hospital, University of Manchester Intestinal Failure Unit, Salford, UK.
Br J Surg. 1996 Sep;83(9):1226-9. doi: 10.1046/j.1365-2168.1996.02308.x.
An economic evaluation of home parenteral nutrition (HPN) for intestinal failure is presented. The cost-utility of HPN and factors affecting the cost-utility ratio were examined to determine whether current practice is the most efficient way of treating intestinal failure. Quality-adjusted life-years (QALYs) gained were measured using a validated health status questionnaire. The cost of treating a patient with intestinal failure was calculated, and marginal cost per QALY gained ratios were obtained. The cost per QALY for an average patient was approximately 68,975 pounds, but the value for patients over 55 years of age of about 126,865 pounds compared with approximately 58,233 pounds for those under 44 years. Treating a patient in hospital rather than at home increased the estimated cost per QALY to approximately 190,000 pounds. The current practice of home care is about 65 per cent more cost-effective than hospital care.
本文对家庭肠外营养（HPN）用于肠衰竭进行了经济学评估。研究了HPN的成本效益及影响成本效益比的因素，以确定当前的治疗方式是否为治疗肠衰竭的最有效方法。使用经过验证的健康状况问卷来衡量获得的质量调整生命年（QALY）。计算了治疗一名肠衰竭患者的成本，并得出每获得一个QALY的边际成本比。平均每位患者每QALY的成本约为68,975英镑，但55岁以上患者的该数值约为126,865英镑，而44岁以下患者约为58,233英镑。在医院而非家中治疗患者会使每QALY的估计成本增加到约190,000英镑。目前的家庭护理做法比医院护理的成本效益高约65%。
